Indian Journal of Urology Users online:1105  
IJU
Home Current Issue Ahead of print Editorial Board Archives Symposia Guidelines Subscriptions Login 
Print this page  Email this page Small font sizeDefault font sizeIncrease font size
This article has been cited by
1The Safety and Efficacy of Different Doses of Bacillus Calmette Guérin in Superficial Bladder Transitional Cell Carcinoma
Madhu S. Agrawal,Moneet Agrawal,Sumit Bansal,Mayank Agarwal,Prashant Lavania,Jitendra Goyal
Urology.2007;70(6)1075
[DOI]
2Intravesical Bacillus Calmette-Guerin (BCG) Therapy for Non-muscle Invasive Bladder Cancers: Long-term Results of a Modified Schedule
Kanuj Malik,Anand Raja,Lalgudi Subramaniam Ravishankar,Kathiresan Narayanaswamy,Venkatraman Radhakrishnan,Tenali Gnana Sagar
Indian Journal of Surgical Oncology.2021;70(6)1075
[DOI]
3Intravesical bacillus Calmette-Guerin (BCG) in treating non-muscle invasive bladder cancer—analysis of adverse effects and effectiveness of two strains of BCG (Danish 1331 and Moscow)
Yuvaraja B. Thyavihally,Preetham Dev,Santosh Waigankar,Abhinav Pednekar,Nevitha Athikari,Abhijit Raut,Archan Khandekar,Naresh Badlani,Ashishkumar Asari
Asian Journal of Urology.2021;70(6)1075
[DOI]
4Dose, duration and strain of bacillus Calmette–Guerin in the treatment of nonmuscle invasive bladder cancer
Yongjun Quan,Chang Wook Jeong,Cheol Kwak,Hyeon Hoe Kim,Hyung Suk Kim,Ja Hyeon Ku
Medicine.2017;96(42)e8300
[DOI]
  Search 
  The Journal 
  The Association 
  Site Statistics 
  Addresses 
  e-Alerts 
  Online Submission 

Submit Articles

Alerts

Join us